Skip to content

Vestibular First Insight Infrared Video Goggles ProRecalls & reported problems

Vestibular First, LLC · The Insight Infrared Video Goggles Pro are intended for viewing and recording eye movements in support of identifying vestibular disorders in patients. The device is intended for use only by a trained healthcare professional in an appropriate healthcare setting. This device provides no diagnoses nor does it provide diagnostic recommendations. The target population is 12+ years of age. · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00860002280738), received between Jan 18, 2024 and Jan 18, 2024 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 1 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Skin Inflammation/ Irritation1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJan 18, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    PATIENT CONTACTED VESTIBULAR FIRST ON 22-DEC-2023 AND REPORTED POSSIBLE ALLERGIC REACTION AROUND EYE AREA AFTER ASSESSMENT WITH INSIGHT PRO GOGGLES ON 20-DEC-2023. THE ALLERGIC REACTION WAS NOT AT THE AREAS WHERE THE GOGGLES CONTACT SKIN AT THE FOREHEAD, SIDE OF CHEEKS AND NOSE BRIDGE, BUT WAS AT THE EYE AREA THAT DOES NOT HAVE CONTACT WITH THE GOGGLES (EYELID AND BELOW THE EYE). FACILITY ROUTINELY USES MEMBER'S MARK DISINFECTING WIPES BETWEEN PATIENTS' USE. MSDS FOR MEMBER'S MARK INCLUDES ACTIVE INGREDIENTS ALKYL DIMETHYL BENZYL AMMONIUM CHLORIDE AND ALKYL DIMETHYL ETHYL BENZYL AMMONIUM CHLORIDE THAT ARE REPORTED AS IRRITANTS TO THE EYES. VESTIBULAR FIRST RECOMMENDS ONLY 70% ISOPROPYL ALCOHOL FOR DISINFECTING BETWEEN PATIENTS' USE.

    Patient problems: Skin Inflammation/ Irritation

    MAUDE report 18535371 ↗

Other Nystagmograph devices

All Nystagmograph devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page